RU2018105003A - Композиции, содержащие аморфный эмодепсид - Google Patents

Композиции, содержащие аморфный эмодепсид Download PDF

Info

Publication number
RU2018105003A
RU2018105003A RU2018105003A RU2018105003A RU2018105003A RU 2018105003 A RU2018105003 A RU 2018105003A RU 2018105003 A RU2018105003 A RU 2018105003A RU 2018105003 A RU2018105003 A RU 2018105003A RU 2018105003 A RU2018105003 A RU 2018105003A
Authority
RU
Russia
Prior art keywords
spp
emodepside
nematode
amorphic
compositions containing
Prior art date
Application number
RU2018105003A
Other languages
English (en)
Other versions
RU2018105003A3 (ru
RU2761529C2 (ru
Inventor
Венката-Рангарао КАНИКАНТИ
Петра ЛАНГЕ
Ханс-Юрген ХАМАНН
Петер КЛЯЙНЕБУДДЕ
Original Assignee
Байер Фарма Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47358491&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2018105003(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байер Фарма Акциенгезельшафт filed Critical Байер Фарма Акциенгезельшафт
Publication of RU2018105003A publication Critical patent/RU2018105003A/ru
Publication of RU2018105003A3 publication Critical patent/RU2018105003A3/ru
Application granted granted Critical
Publication of RU2761529C2 publication Critical patent/RU2761529C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Claims (4)

1. Способ лечения или профилактики от эндопаразита, включающий введение нуждающемуся в этом человеку или животному эффективного количества фармацевтической композиции, содержащей эмодепсид в поливинилпирролидоновой матрице, причем по меньшей мере 50% эмодепсида находятся в аморфном состоянии.
2. Способ по п. 1, причем эндопаразит представляет собой гельминт, выбранный из нематоды.
3. Способ по п. 2, причем эндопаразит представляет собой нематоду, выбранную из отряда Trichinellida, Tylenchida, Rhabditina, Spirurida.
4. Способ no п. 3, причем нематода выбрана из Trichuris spp., Trichinella spp., Strongyloides spp., Ancylostoma spp., Enterobius spp., Ascaris spp., Toxascaris spp., Dracunculus spp., Loa spp., Brugia spp., Wuchereria spp., Onchocerca spp.
RU2018105003A 2011-12-21 2012-12-18 Композиции, содержащие аморфный эмодепсид RU2761529C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194878.2 2011-12-21
EP11194878 2011-12-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2014129620A Division RU2651761C2 (ru) 2011-12-21 2012-12-18 Композиции, содержащие аморфный эмодепсид

Publications (3)

Publication Number Publication Date
RU2018105003A true RU2018105003A (ru) 2019-02-22
RU2018105003A3 RU2018105003A3 (ru) 2021-06-11
RU2761529C2 RU2761529C2 (ru) 2021-12-09

Family

ID=47358491

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2014129620A RU2651761C2 (ru) 2011-12-21 2012-12-18 Композиции, содержащие аморфный эмодепсид
RU2018105003A RU2761529C2 (ru) 2011-12-21 2012-12-18 Композиции, содержащие аморфный эмодепсид

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2014129620A RU2651761C2 (ru) 2011-12-21 2012-12-18 Композиции, содержащие аморфный эмодепсид

Country Status (24)

Country Link
US (3) US9539331B2 (ru)
EP (1) EP2793861B1 (ru)
JP (1) JP6185930B2 (ru)
KR (2) KR101978620B1 (ru)
CN (2) CN108187028A (ru)
AU (2) AU2012357848C1 (ru)
BR (1) BR112014014973A2 (ru)
CA (1) CA2859787C (ru)
CL (1) CL2014001637A1 (ru)
CO (1) CO6990713A2 (ru)
CR (1) CR20140293A (ru)
DO (1) DOP2014000140A (ru)
EC (1) ECSP14005917A (ru)
ES (1) ES2734352T3 (ru)
HK (1) HK1255536A1 (ru)
IL (1) IL233183B (ru)
MX (2) MX368209B (ru)
MY (1) MY175307A (ru)
NI (1) NI201400065A (ru)
PH (2) PH12014501438B1 (ru)
RU (2) RU2651761C2 (ru)
UA (1) UA115232C2 (ru)
WO (1) WO2013092558A1 (ru)
ZA (1) ZA201404529B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX368209B (es) 2011-12-21 2019-09-24 Bayer Pharma Ag Star Preparaciones que comprenden emodepsido amorfo.
SG10202103403SA (en) 2015-05-20 2021-05-28 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic depsipeptide compounds
CN108699052B (zh) 2015-12-28 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
CA3044038A1 (en) 2016-11-16 2018-05-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
CN114195732A (zh) * 2022-01-04 2022-03-18 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型iii及其制备方法
CN115444927B (zh) * 2022-09-19 2023-06-02 山东第一医科大学附属肿瘤医院(山东省肿瘤防治研究院、山东省肿瘤医院) 艾默德斯在制备治疗三阴性乳腺癌的药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE211466T1 (de) * 1992-03-17 2002-01-15 Fujisawa Pharmaceutical Co Depsipeptide, herstellung und anwendung
DE19918325A1 (de) * 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10000792A1 (de) * 2000-01-11 2001-07-19 Bernhard C Lippold Formulierungen von Wirkstoffen in Form einer festen Dispersion
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
RU2315614C1 (ru) * 2006-04-19 2008-01-27 Бийтемир Ахмедович Султанбеков Средство "грепол" и способ применения его при паразитарных заболеваниях
RU2425825C2 (ru) * 2007-02-09 2011-08-10 Пфайзер Лимитед Амидоацетонитрильные производные, содержащие их фармацевтические композиции и их применение в изготовлении лекарственного средства
DE102008022520A1 (de) 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
EP2355802A1 (de) * 2008-11-14 2011-08-17 Ratiopharm GmbH Intermediate und orale darreichungsformen enthaltend lenalidomid
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
MX368209B (es) 2011-12-21 2019-09-24 Bayer Pharma Ag Star Preparaciones que comprenden emodepsido amorfo.

Also Published As

Publication number Publication date
MX368209B (es) 2019-09-24
MX2014007224A (es) 2014-09-22
KR20180084141A (ko) 2018-07-24
JP6185930B2 (ja) 2017-08-23
NI201400065A (es) 2015-12-10
KR101978620B1 (ko) 2019-08-28
NZ625817A (en) 2016-08-26
US10251932B2 (en) 2019-04-09
MX356094B (es) 2018-05-14
AU2012357848B2 (en) 2018-01-04
KR20140107296A (ko) 2014-09-04
UA115232C2 (uk) 2017-10-10
CR20140293A (es) 2014-07-14
CO6990713A2 (es) 2014-07-10
HK1255536A1 (zh) 2019-08-23
CN104023710A (zh) 2014-09-03
EP2793861B1 (de) 2019-05-01
DOP2014000140A (es) 2014-07-31
ES2734352T3 (es) 2019-12-05
US20170182118A1 (en) 2017-06-29
CA2859787A1 (en) 2013-06-27
AU2018202376B2 (en) 2019-06-20
PH12018500368A1 (en) 2018-07-23
US20180153957A1 (en) 2018-06-07
RU2018105003A3 (ru) 2021-06-11
US9539331B2 (en) 2017-01-10
WO2013092558A1 (de) 2013-06-27
PH12014501438A1 (en) 2014-10-08
AU2012357848A1 (en) 2014-07-10
CA2859787C (en) 2020-09-08
IL233183A0 (en) 2014-07-31
RU2761529C2 (ru) 2021-12-09
JP2015502377A (ja) 2015-01-22
MY175307A (en) 2020-06-18
US20140371139A1 (en) 2014-12-18
CN108187028A (zh) 2018-06-22
BR112014014973A2 (pt) 2017-06-13
RU2014129620A (ru) 2016-02-10
RU2651761C2 (ru) 2018-04-23
AU2012357848C1 (en) 2018-07-19
AU2018202376A1 (en) 2018-04-26
EP2793861A1 (de) 2014-10-29
IL233183B (en) 2020-01-30
PH12014501438B1 (en) 2014-10-08
KR101979049B1 (ko) 2019-05-15
ZA201404529B (en) 2017-06-28
ECSP14005917A (es) 2015-12-31
CL2014001637A1 (es) 2014-11-21

Similar Documents

Publication Publication Date Title
RU2018105003A (ru) Композиции, содержащие аморфный эмодепсид
CL2015001945A1 (es) (divisional de la solicitud n° 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
BRPI0812954A2 (pt) Composição herbicidamente ativa, método para controlar vegetação indesejada, e, uso de composições
MX365657B (es) Composición novedosa y método de uso para controlar patógenos y prevenir enfermedades en semillas.
BR112015005094A2 (pt) misturas de pesticidas, métodos para controle, método de proteção, semente, uso de uma mistura, método para melhorar a saúde de plantas e composição pesticida.
CL2008000592A1 (es) Compuestos derivados de pirrol sustituido, supresores de la secrecion de acidos; composicion farmaceutica; y uso en el tratamiento o profilaxis en enfermedades tales como ulcera peptica, gastritis, esofagitis, entre otras.
BRPI0816948A2 (pt) Composição fungicida para controlar fungos nocivos fitopatogênicos, agente fungicida, método para controlar fungos nocivos fitopatogênicos, semente, e, uso dos componentes
RS54548B1 (en) COMPOSITIONS CONTAINING ORGANIC ACID MONOGLICERIDES WITH C1 TO C7 AND GLYCEROL, THEIR PREPARATION AND USE AS ANTIBACTERIAL AND ANTIGLIVIC AGENAS
ZA201307224B (en) (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 triazinyl bemzimidazoles, pahrmaceutical compositions containing them, and these compounds for use in treating proliferative deseases
AR085204A1 (es) Mezclas agroquimicas para aumentar la salud de una planta
WO2009007328A3 (de) Verwendung von homo- und copolymeren zur stabilisierung von wirkstoffformulierungen
BRPI0912385A2 (pt) Método para proteger plantas de soja de serem infectadas por fungos nocivos, composição fungicida, agente fungicida, semente, e, uso de uma composição
MX2010007677A (es) Derivados de hidroximoil-tetrazol como fungicidas.
MX2009007206A (es) Mezclas de pesticidas.
WO2011160024A3 (en) Compounds useful as antiviral agents, compositions, and methods of use
WO2008132021A3 (de) Fungizide mischungen
MX2016000199A (es) Un metodo para controlar plagas que habitan en la superficie del agua.
AU2016216741A1 (en) Compositions and methods of use of an inappetance-controlling compound
SG195175A1 (en) Pesticide compositions containing thyme oil and cinnamon oil
AR075274A1 (es) Agente de tratamiento de semillas y metodo para proteger una planta
AR066864A1 (es) Composicion parasiticida veterinaria, uso de la misma y metodo para el tratamiento o control de una infestacion o infeccion parasiticida en un animal homeotermico
BR112014000080A2 (pt) dispositivo de reconstituição
BR112015005347A2 (pt) composto, composição farmacêutica, e, método para tratamento ou profilaxia de infecção por hiv ou para tratamento, profilaxia, ou atraso no início de aids
WO2011080254A3 (en) Fungicide hydroximoyl-heterocycles derivatives
MX2009007566A (es) Mezclas pesticidas.